Service
Tried two antidepressants. Still stuck. That pattern qualifies you for the one medication the FDA approved specifically for your situation. Our Spravato treatment clinic in Telford TN provides insurance-covered esketamine nasal spray — the first new class of antidepressant in over three decades.
Not a One-Size-Fits-All Approach — Physician-Guided Esketamine Tailored to Your Specific Response
Telford sits in the heart of Washington County’s rural corridor — a quiet community between Johnson City and Greeneville where families have put down roots for generations. Life here moves with intention, and so should your treatment. If two or more antidepressants have come and gone without breaking your depression’s grip, the answer isn’t another pill from the same shelf. It’s a medication designed from a completely different blueprint.
Spravato (esketamine nasal spray) earned its FDA approval by proving what no serotonin-based antidepressant could: rapid, measurable relief for the specific population of patients whose depression resists conventional treatment. Revitalist is a fully REMS-certified provider based at our Johnson City clinic on Red Bush Court — minutes from Telford along US 11-E.
But what separates our approach isn’t just offering Spravato. It’s how we use it. Depression doesn’t present identically in every patient, and treatment response varies based on individual biology, symptom profile, and clinical history. Our physicians personalize every element of your Spravato protocol — dosing, schedule, maintenance frequency — based on how your brain actually responds, not a generic formula.
What Spravato treatment in Telford TN through Revitalist means for you:
FDA-approved esketamine designed specifically for treatment-resistant depression
Personalized dosing and scheduling based on your individual response patterns
Insurance coverage through most commercial and government health plans
Symptom improvement documented within 24 hours in clinical trials
Physician-supervised nasal spray — no IVs, no injections, no hospital stays
83% of our patients report significant improvement after completing their initial treatment series.
Spravato isn’t simply “a stronger antidepressant.” It’s a fundamentally different pharmacological tool that requires a fundamentally different clinical approach. The medications you’ve tried before were prescribed, taken at home daily, and assessed at follow-up visits weeks later. Spravato is administered in-clinic, under physician supervision, with real-time monitoring that allows your treatment team to observe and adjust based on how you respond — session by session, dose by dose.
What Makes Spravato Distinct:
Different Brain System: Targets glutamate through NMDA receptor antagonism — completely separate from the serotonin system every previous antidepressant used
In-Clinic Observation: Every session includes direct physician supervision and two-hour monitoring, enabling real-time response assessment
Adaptive Dosing: Protocol adjusts based on your individual response, not a one-size template
FDA-Backed: Triple approval — TRD (2019), suicidal ideation (2020), monotherapy (2025) — with Breakthrough Therapy designation
Insurance-Covered: FDA approval makes Spravato eligible for coverage through most health plans
A pivotal study published in JAMA Psychiatry confirmed that patients who continued Spravato treatment after achieving remission experienced significantly lower relapse rates than those switched to placebo. Among patients in stable remission, those who stayed on esketamine maintained their gains at rates that far outperformed the control group — critical evidence that Spravato doesn’t just produce temporary relief but sustains it over time.
Speed of Relief
Spravato® Therapy
Hours to days
Traditional Antidepressants
Success Rate
Spravato® Therapy
Traditional Antidepressants
10-30% for treatment-resistant cases
Spravato® Therapy
Often covered for approved indications
Traditional Antidepressants
Generally covered but limited effectiveness
Mechanism of Action
Spravato® Therapy
Glutamate/NMDA system
Traditional Antidepressants
Serotonin/dopamine systems
Spravato® Therapy
Traditional Antidepressants
Daily self-administered pills
Spravato® Therapy
Traditional Antidepressants
Often persistent and ongoing
“I run cattle on a farm between Telford and Limestone, and depression doesn’t care about calving season or fence lines that need mending. Three years of it — Paxil first, then Effexor, then both together. Nothing changed except my weight. When my doctor mentioned the Spravato treatment clinic in Telford TN area at Revitalist, I figured it was another swing-and-miss. My insurance covered it after prior authorization, and by session four, I finished morning chores without sitting on the gate for twenty minutes trying to find the motivation to keep going. That was the first real change in three years.”
— Dale C., Telford, TN Patient
“I’m a school bus driver covering routes through Telford and the surrounding communities. Depression turned what should be a straightforward job into something I dreaded every morning. Two antidepressants over eighteen months — my doctor was honest that we’d run through the easy options. She referred me to the best Spravato treatment clinic in Telford and explained it was a nasal spray, not another pill. After my third session, I caught myself singing along to the radio on my route. That sounds silly, but I hadn’t done it in over a year. By the end of induction, getting out of bed stopped feeling like a negotiation.”
— Rhonda S., Telford, TN Patient
“After my wife passed, I moved to Telford to be closer to my daughter and her family. The grief turned into clinical depression within six months. My daughter’s doctor tried two medications that both left me foggy and numb without touching the depression itself. My daughter researched Spravato treatment in Telford TN and found Revitalist in Johnson City. I was seventy-two and skeptical of anything new. But after five sessions, I sat at the dinner table with my grandchildren and actually participated in the conversation instead of staring at my plate. My daughter said it was the first time since the funeral that I seemed present.”
— Gene H., Telford, TN Patient
Every session is observed. Every dose is adjustable. Every maintenance schedule is personalized to your response. That’s what physician-supervised, REMS-monitored treatment looks like — and it’s why Spravato produces results that take-home prescriptions couldn’t.
Spravato holds targeted FDA approvals, and our broader clinical platform covers the full range of resistant conditions facing Telford and Washington County residents:
When two or more antidepressants haven’t provided adequate relief
Rapid intervention for patients with active suicidal thoughts
Standard antidepressants follow a blunt protocol: prescribe, wait four to eight weeks, assess, switch if necessary, repeat. That approach provides zero real-time data. By the time you know a medication isn’t working, you’ve lost weeks. Spravato’s in-clinic model inverts that equation.
Esketamine blocks NMDA receptors in the glutamate network, triggering two simultaneous repair cascades:
These processes begin within hours of administration — not the weeks required for serotonin reuptake adaptation. And because the S-enantiomer in Spravato binds NMDA receptors with approximately four times the affinity of the R-enantiomer, the therapeutic effect is concentrated and targeted.
These pathways likely converge through shared downstream signaling (mTOR may serve as a node where both BDNF-TrkB signaling and AMPA-mediated cascades meet), amplifying each other’s effects. The result is a neuroplastic response that’s both faster and more robust than anything a single-mechanism medication can produce.
At Revitalist, this isn’t theoretical. It’s how we practice. Every Telford patient’s protocol reflects their individual response data, not a standardized flowchart.
Telford residents face a reality common across rural Appalachia: limited access to psychiatric specialists, longer drives to treatment facilities, and a healthcare infrastructure that often prioritizes acute care over chronic mental health conditions. Spravato’s structured, in-clinic model addresses part of this gap by providing intensive, physician-supervised treatment on a defined schedule — with the kind of real-time monitoring that remote prescription management can’t replicate.
Treatment starts with a comprehensive consultation. Our physicians examine your full psychiatric and medical history, confirm treatment-resistant status, and screen for contraindications. Insurance verification begins the same visit — benefits, prior authorization, and cost transparency. Telford residents leave with definitive answers.
Our Johnson City clinic at 2 Red Bush Court is a quick drive from Telford on US 11-E. Each session begins with blood pressure measurement and a clinical check-in.
You self-administer the nasal spray under our team’s supervision — about fifteen minutes total. Then you spend two hours in a private room while we monitor vitals and check on you at regular intervals. Patients consistently describe this time as unexpectedly valuable — a rare pocket of calm in a full week.
We maintain direct communication with your Johnson City-area psychiatrist, therapist, or primary care physician. Spravato produces its best outcomes when every provider involved in your care stays informed and aligned — and we make that coordination a standard part of how we operate.
Federal REMS requirements govern every Spravato session. At Revitalist, those requirements form the foundation of our entire clinical operation — staff training, monitoring systems, documentation practices, and emergency readiness all exceed the regulatory baseline. The best Spravato treatment clinic in Telford builds above the standard, not to it.
Our team navigates the full prior authorization process — benefits verification, clinical documentation, carrier communication, and ongoing reauthorizations. Telford patients focus on recovery. We focus on access.
Thousands of ketamine and esketamine treatments administered. Years of refined protocols. The kind of clinical pattern recognition that produces better dosing decisions, smoother side-effect management, and stronger outcomes for every patient.
Private rooms. Comfortable seating. Warm lighting. An atmosphere designed for rest and reflection. The two-hour monitoring period at our clinic feels restorative — patients tell us it's often the most restful stretch in their week.
Limestone sits at the junction of Washington and Greene County — two communities whose residents have limited access to specialized psychiatric care without traveling to larger cities. Revitalist bridges that gap by providing FDA-approved, insurance-covered treatment right here in the Tri-Cities region, so Limestone residents can access advanced care without a three-hour drive.
Clinical assessment determines the recommendation: Spravato (Esketamine) — FDA-approved, insurance-covered nasal spray for treatment-resistant depression IV Ketamine Therapy — Intravenous delivery for TRD, PTSD, anxiety, chronic pain, and additional resistant conditions Vitamin Infusion Therapy — Brain health and nutritional support alongside primary treatment
Spravato® safety profile has been studied extensively through Phase 3 clinical trials involving thousands of patients, plus years of real-world use since its 2019 approval. The REMS program exists to ensure that every administration occurs under conditions designed to minimize risk.
These effects typically resolve within 1-2 hours after treatment ends. Our medical team provides continuous monitoring throughout your session and observation period to ensure your comfort and safety.
Spravato® therapy may not be appropriate for individuals with:
During your consultation, our medical team will thoroughly review your health history and current medications to determine if Spravato® therapy is safe and appropriate for you.
Many patients report noticeable improvements within hours or days of their first treatment. Unlike traditional antidepressants that can take 4-8 weeks to show effects, Spravato’s rapid action through the glutamate system often provides relief during the first treatment session.
The FDA-approved protocol includes twice-weekly treatments for the first month (induction phase), weekly treatments for the second month (maintenance phase), and then weekly or bi-weekly treatments based on your response (continuation phase). Your specific protocol will be customized based on your individual needs and response to treatment.
Yes, many major insurance plans cover Spravato for FDA-approved indications like treatment-resistant depression. Coverage typically requires prior authorization and documentation of previous treatment failures. Our team will verify your specific benefits and guide you through the approval process.
No, you cannot drive or operate machinery until the next day after receiving Spravato. You must arrange transportation home after each session. This is a mandatory safety requirement due to the medication’s effects on cognition and coordination.
Your first session will begin with final preparations and a review of the self-administration process. You’ll use the simple nasal spray device under our medical team’s supervision, then relax in our comfortable treatment room during the required 2-hour monitoring period. Our staff will ensure your comfort and safety throughout the entire process.
Spravato is FDA-approved specifically for treatment-resistant depression and is often covered by insurance, while ketamine infusions are used off-label for various conditions and typically aren’t covered. Spravato is self-administered as a convenient nasal spray, while ketamine requires IV infusion. Both contain the same active compound but in different formulations.
Yes, Spravato was specifically developed and FDA-approved for treatment-resistant depression. Clinical trials demonstrated significant effectiveness in patients who had failed to respond to multiple previous antidepressants. The unique glutamate mechanism offers hope when serotonin-based treatments haven’t provided relief.
No, Spravato is designed to be used alongside an oral antidepressant as combination therapy. You should continue your current medications unless specifically directed otherwise by your healthcare provider. Our medical team will review your medications and coordinate with your psychiatrist as needed.
Long-term studies show that continued Spravato treatment can provide sustained improvement in depression symptoms with manageable side effects. The SUSTAIN studies demonstrated that patients who responded to initial treatment could maintain their improvement with ongoing therapy. Regular monitoring ensures safe, effective long-term use.
Take the first step toward healing:
Free Assessment
Personalized treatment plan designed for your specific condition
Rapid relief often within hours of your first treatment
Insurance coverage verification and prior authorization support
Compassionate care from experienced mental health professionals